SILVIA MARIA DÍAZ PRADO | Drug Delivery Systems | Lifetime achievement Award

Published on by Top Pharmaceutical

SILVIA MARIA DÍAZ PRADO | Drug Delivery Systems | Lifetime achievement Award

Prof. Dr. SILVIA MARIA DÍAZ PRADO, University of A Coruña, Spain

Prof. Dr. Silvia María Díaz Prado is a Professor of Anatomy at the University of A Coruña and leads the Cellular Therapy and Regenerative Medicine Group at INIBIC. With a PhD in Biology (2004), her research spans tissue engineering, stem cells 🧬 (including iPSCs), novel biomaterials, 3D bioprinting 🖨️, and nanoparticle drug delivery 💊. She has published 68 articles (H-index: 24), 32 book chapters, and presented at 215 conferences. Dr. Díaz Prado has led 33 research projects, supervised over 50 theses, and received 7 research awards 🏅. She coordinates the Master’s in Health Care and Research program.

Publication Profile

Google Scholar

Education

Prof. Dr. Silvia María Díaz Prado 🎓 holds a Ph.D. in Biology (2004) from the University of A Coruña, where she serves as a Professor of Anatomy 🧠 and coordinates the Master’s Degree in Health Care and Research 💉📚. With a distinguished academic career, she has played a pivotal role in shaping advanced medical education and fostering scientific inquiry 🔬. Her dedication to teaching and mentorship has inspired countless students and researchers, reinforcing her status as a respected leader in the biomedical field 🌟. Prof. Dr. Díaz Prado continues to advance excellence in health sciences through education and innovation.

Awards

Prof. Dr. Silvia María Díaz Prado 🏅 has been honored with seven prestigious research awards 🧪, reflecting the high regard in which her scientific contributions are held by the academic community 🌍. These accolades underscore her exceptional merit, dedication to innovation, and impactful work in the field of biomedical research 🧬. Each award stands as a testament to her relentless pursuit of knowledge, excellence, and advancement in science 🔍✨. Prof. Díaz Prado’s achievements not only bring recognition to her individual efforts but also elevate the institutions and research teams she represents, inspiring future generations of scientists 🎓🌟.

Research Focus

Prof. Dr. Silvia María Díaz-Prado is a distinguished researcher in the field of Regenerative Medicine 🧬🦴, with a strong focus on stem cells, cartilage repair, and molecular signaling in musculoskeletal disorders. Her groundbreaking work explores microRNA profiling🧪, mesenchymal stem cells🧫, and the human amniotic membrane as a novel source for cell therapy. She also investigates oncogenic pathways like Wnt, Notch, and Hedgehog 🔬, linking them to cancer stem cells. Prof. Díaz-Prado’s contributions bridge molecular biology with clinical applications, making her a key figure in orthopedic tissue engineering, biomarkers, and cell-based therapeutic strategies.

Publication Top Notes

Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes

Cloning genes from a library using a clustering strategy and PCR

Multilineage differentiation potential of cells isolated from the human amniotic membrane

Human amniotic membrane as an alternative source of stem cells for regenerative medicine

Wnt signalling and cancer stem cells

Notch signalling in cancer stem cells

Potential use of the human amniotic membrane as a scaffold in human articular cartilage repair

Quantification of cells expressing mesenchymal stem cell markers in healthy and osteoarthritic synovial membranes

Effects of severe hypoxia on bone marrow mesenchymal stem cells differentiation potential

Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer

Isolation and characterization of mesenchymal stem cells from human amniotic membrane

Induced pluripotent stem cells for cartilage repair: current status and future perspectives

Biology of BMP signalling and cancer

Oliwia Kordyl | Drug Delivery Systems | Best Research Article Award

Published on by Top Pharmaceutical

Oliwia Kordyl | Drug Delivery Systems | Best Research Article Award

Ms. Oliwia Kordyl, Poznan Univeristy of Medical Sciences, Poland

Ms. Oliwia Kordyl (b. June 9, 1997) is a dedicated PhD student at Poznan University of Medical Sciences, specializing in 3D printed microneedles for targeted drug delivery. With a background in biotechnology from Adam Mickiewicz University, her work spans molecular biology, pharmaceutical technology, and reproductive genetics. Oliwia has held roles as a lab manager, molecular biologist, and biotechnologist, contributing to innovative projects and scientific conferences. She is skilled in advanced lab techniques and passionate about travel, fitness, and continuous learning.

Publication Profile

orcid

Education

Ms. Oliwia Kordyl is currently pursuing her Ph.D. (Nov 2023–Present) at the Poznan University of Medical Sciences in Poland, focusing on 3D printed microneedles for voriconazole delivery in treating local skin infections. Her research involves optimizing microneedle manufacturing, assessing physicochemical and pharmaceutical properties in vitro, and evaluating drug permeation ex vivo and microbiological effectiveness 🧪🧬. She earned her M.Sc. and B.Sc. in biotechnology from Adam Mickiewicz University (2016–2021), where she explored DNA methylation in oligozoospermia and gene expression in spermatogenesis 🧫. Her academic journey began at K.K. Baczyński Secondary School, specializing in biology, physics, and chemistry 🔬📚.

Experience

Ms. Oliwia Kordyl completed a valuable internship at Novazym Polska in Poznań from July to August 2019. During her time at this renowned biotechnology company, she gained hands-on experience in laboratory techniques and deepened her understanding of industrial biotechnology practices 🔬💼. The internship provided her with practical insights into the daily operations of a biotech firm and allowed her to apply her academic knowledge in a real-world setting 🧪📊. This experience not only enhanced her technical skills but also strengthened her passion for research and innovation in the field of biotechnology, laying a strong foundation for her future scientific endeavors 🚀.

Awards

🏆 Ms. Oliwia Kordyl has actively contributed to the scientific community through speeches and posters at esteemed conferences. She presented on sperm DNA methylation at the 21st Andrology Day (2019) 🧬 and the 21st European Testis Workshop (2021) in Barcelona. Her posters featured at ESHRE 2020, the European Human Genetics Conference (2021), and the 6th Polish Congress of Genetics (2022) showcased her expertise in epigenetics and sperm chromatin structure 🧫📊. In 2023, she co-authored a poster on microneedles for transdermal drug delivery at PolGerSym10 💉. Oliwia also co-authored a publication in the International Journal of Molecular Sciences (2022) 📄📚.

Research Focus

Ms. Oliwia Kordyl’s research focuses on the development of innovative drug delivery systems, particularly microneedle-based technologies for transdermal applications. Her work combines 3D printing, pharmaceutical coatings, and hydrogel systems to enhance the treatment of bacterial and fungal skin infections. She also explores photodynamic therapy and nanotechnology for targeted drug release. Her interdisciplinary approach bridges materials science, biomedical engineering, and pharmaceutics. Additionally, her research extends to epigenetic analysis in human sperm, highlighting her interest in reproductive biology. Her work is at the frontier of personalized medicine, non-invasive therapies, and advanced pharmaceutical technologies.

Publication Top Notes

Optimization of LCD-Based 3D Printing for the Development of Clotrimazole-Coated Microneedle Systems

Microneedle-based arrays – Breakthrough strategy for the treatment of bacterial and fungal skin infections

Microneedle System Coated with Hydrogels Containing Protoporphyrin IX for Potential Application in Pharmaceutical Technology

Global 5mC and 5hmC DNA Levels in Human Sperm Subpopulations with Differentially Protaminated Chromatin in Normo- and Oligoasthenozoospermic Males

Shoaeb Mohammad Syed | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Shoaeb Mohammad Syed | Drug Delivery Systems | Best Researcher Award

Dr Shoaeb Mohammad Syed, Dayanand College of Pharmacy Latur, India

Dr. Shoaeb Mohammad Syed is an Associate Professor at Dayanand College of Pharmacy, Latur, India. With extensive experience in pharmaceutics, formulation development, and novel drug delivery systems, he mentors M.Pharm and Ph.D. students and guides research projects. He has two granted patents and authored several books and research publications. Dr. Syed is actively involved in curriculum development, research mentorship, and academic leadership. His work spans areas like drug delivery, nano drug systems, and quality control. He has also contributed to multiple national and international conferences. 🏫💊📚🔬📜💡🎓

Publication Profile

Google Scholar

Education

Dr. Shoaeb Mohammad Syed holds a PhD in Pharmacy from Govt. College of Pharmacy, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad (2014-2019). He completed his postgraduate studies in Pharmaceutics at Y B Chavan College of Pharmacy, Dr. BAMU Aurangabad, securing 74.45% (2010-2012). He earned his undergraduate degree in Pharmacy from the same institution with 69.79% (2007-2010). Additionally, he obtained a D. Pharmacy from MSBTE Mumbai, achieving 80.60% (2005-2007). Dr. Syed’s academic journey showcases his dedication and expertise in the field of pharmacy. 🎓💊📚

Experience

Dr. Shoaeb Mohammad Syed is an Associate Professor at Dayanand College of Pharmacy, Latur, India, where he leads research, supports faculty programs, and mentors PhD students. He contributes to curriculum development, research projects, and patent filing. Previously, he was an Assistant Professor at Dr. Vedprakash Patil Pharmacy College, developing publications and managing research proposals. His role as a Research Fellow at Govt. College of Pharmacy focused on formulation development and GMP. Dr. Syed has extensive teaching experience across multiple institutions, creating courses, mentoring students, and publishing research. 📚💡📝🔬🎓

Academic Leadership and Mentoring

Dr. Shoaeb Mohammad has demonstrated exemplary leadership in academia through his guidance of Ph.D. students, fostering a supportive environment for academic growth. His active involvement in research proposal development and grant management underscores his dedication to driving innovative research. Dr. Mohammad’s commitment to academic development is further highlighted by his efforts in organizing conferences and workshops, which contribute to the exchange of knowledge and collaboration within the academic community. His work not only supports the academic growth of individuals but also strengthens the overall academic environment, making a lasting impact on the field. 🌍🎤📚

Professional Impact

Dr. Shoaeb Mohammad, known for his expertise in pharmaceutical sciences, has made significant contributions both in academia and the pharmaceutical industry. With a strong presence in scientific writing, he excels in drafting patents and reviewing manuscripts for various journals, ensuring the advancement of pharmaceutical research. His work spans national and international platforms, influencing the development of the field. Dr. Shoaeb’s commitment to innovation and quality in scientific publishing is evident in his dedication to enhancing the global pharmaceutical landscape. His diverse skills and impact continue to shape the future of pharmaceutical sciences. 🏭📑🌍

Research Focus

Dr. Shoaeb Mohammad Syed’s research focus revolves around the development and evaluation of advanced drug delivery systems. His work emphasizes osmotic drug delivery, gastroretentive systems, and transdermal delivery using novel carriers like ethosomes. He has contributed significantly to the analytical validation of pharmaceutical methods, such as UV spectrophotometry and RP-HPLC for drug estimation. His studies also include controlled-release formulations, such as osmotic tablets for sustained drug release, and the application of microsponges in topical drug delivery. Dr. Syed’s expertise in pharmaceutical formulations and analytical techniques aims to enhance drug bioavailability and therapeutic efficacy. 🧪💊📊

Achievements

Dr. Shoaeb Mohammad is a highly accomplished professional with a strong academic background. He qualified GPAT in 2010, was awarded the AICTE scholarship for his post-graduation, and excelled in the NIPERJEE 2010. He received the UGC-MANF fellowship for his PhD and emerged as the winner of Avishkar Research Convention 2019 at Dr. BAMU, Aurangabad, and was selected for the State Level Avishkar 2020 at the University of Mumbai. Dr. Mohammad developed the MDR Shifa Oil (Pain Relief Liniment), which was approved by the FDA Maharashtra, India. 🏆🎓💊👨‍🔬

Publication Top Notes

Osmotic Drug Delivery System: An Overview.

AN OVERVIEW OF GASTRORETENTIVE DRUG DELIVERY SYSTEM RESEARCH

Transdermal delivery of ethosomes as a novel vesicular carrier for paroxetine hydrochloride: In vitro evaluation and In vivo study

Validation of UV Spectrophotometric Method For Determination of Atenolol

Analytical Method Development and validation of RP-HPLC Method for Determination of Eletriptan HBr.

Controlled Porosity Osmotic Tablet of Atenolol: In-Vitro and In-Vivo Evaluation

Quality by Design: An Approach for Formulation Development

 

 

Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Prof Luisa De Cola, University of Milan and Mario Negri Institute, Italy

Prof. Luisa De Cola is an accomplished chemist known for her interdisciplinary research in supramolecular and materials chemistry, with applications in biomedical fields. She holds a Laurea in Chemistry from the University of Messina and has held prestigious positions at institutions like the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at Istituto Mario Negri, Milan. With over 400 published papers and 42 patents, she has received numerous awards, including the 2020 Gold Medal “Giulio Natta” and 2014 Chevalier de la Légion d’Honneur. 🏅🔬💡

Publication Profile

Google Scholar

Education

Prof. Luisa De Cola, a renowned scientist, earned her Laurea in Chemistry from the University of Messina in 1983. She has held various prestigious academic roles, including Post-doctoral Fellow at Virginia Commonwealth University, and visiting scientist positions at UCLA, Harvard, and MIT. From 1986 to 1990, she worked as a researcher at the National Research Council in Bologna. She later served as a Full Professor at the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at the Mario Negri Institute. 🧪🔬🌍

Experience

Prof. Luisa De Cola is a renowned academic and researcher currently serving as a Full Professor at the University of Milan, Italy, since 2020. She is also the Director of the “Materials for Health” unit at Istituto di Ricerche Farmacologiche Mario Negri in Milan. Her distinguished career includes previous roles at prestigious institutions such as the University of Amsterdam, University of Münster, and University of Strasbourg. Prof. De Cola has held notable positions, including chairing molecular photonic materials and nanoelectronics. Her research contributions span nanoelectronics, nanophotonics, and biomaterials. 🌍📚🔬👩‍🔬

Research achievements

Prof. Luisa De Cola’s research is known for its multidisciplinary approach, driven by curiosity and fundamental exploration, often with practical applications. Her work spans supramolecular and material chemistry, focusing on functional luminescent and electro-luminescent assemblies, optical and electroluminescent devices, and dynamic (breakable) materials for biomedical applications. With over 400 published papers in peer-reviewed journals (H-index = 88, over 27,000 citations on Scopus), her research has been featured in prestigious journals like Nature and Nature Chemistry. Her contributions continue to shape innovations in materials science and biomedicine. 🌟🧪🔬📚💡💉

Peer recognition

Prof. Luisa De Cola is a distinguished chemist, awarded numerous prestigious prizes throughout her career. Her accolades include the 1993 Chemistry Prize from the Accademia di Scienze Fisiche e Matematiche di Napoli, the 1995 Federchimica National Prize, and the 2009 European Research Council Advanced Grant Award (Magic). In 2011, she received the IUPAC Prize for distinguished women in chemistry, followed by the 2014 Chevalier de la Légion d’Honneur. Other honors include the 2019 Izatt–Christensen Award, 2020 Giulio Natta Gold Medal, and the 2024 Centenary Prize for Chemistry and Communication. She is also an Honorary Professor at Tianjin University and a Doctor Honoris Causa from Universidad Internacional Menéndez Pelayo. 🏆🔬🎖️🌟

Research Focus

Prof. Luisa De Cola’s research focuses on advanced materials, particularly in the development of luminescent and electrochemical systems for various applications. Her work involves the synthesis and characterization of ruthenium and osmium complexes, often in multi-component systems, exploring their electrochemical behavior, absorption spectra, and photoinduced processes. She investigates biomimetic self-assembly for imaging applications, the creation of highly luminescent lanthanide complexes, and photoinduced energy and electron transfer in dinuclear complexes. Her studies have applications in photonic devices, electroluminescence, and molecular imaging. Her work intersects chemistry, material science, and biological applications. 🔬💡🔋✨

Publication Top Notes

Ruthenium (II) and osmium (II) bis (terpyridine) complexes in covalently-linked multicomponent systems: synthesis, electrochemical behavior, absorption spectra, and …

Controlling and imaging biomimetic self-assembly

White‐light emission from an assembly comprising luminescent iridium and europium complexes

Highly luminescent, triple-and quadruple-stranded, dinuclear Eu, Nd, and Sm (III) lanthanide complexes based on bis-diketonate ligands

When self-assembly meets biology: luminescent platinum complexes for imaging applications

Photoinduced energy and electron transfer processes in rigidly bridged dinuclear Ru/Os complexes

Electroluminescent device with reversible switching between red and green emission

 

YORINOBU MAEDA | Drug Delivery Systems | Pharmaceutical Advancement Award

Published on by Top Pharmaceutical

YORINOBU MAEDA | Drug Delivery Systems | Pharmaceutical Advancement Award

Prof Dr YORINOBU MAEDA, Fukuyama university, Japan

Prof. Dr. Yorinobu Maeda, Ph.D. (Hiroshima University, 1990), is a renowned expert in drug safety, pharmacokinetics, and infection control. As a professor at Fukuyama University and Drug Safety Director, he has advanced renal function-based dosing and prescription optimization. His contributions have earned him multiple awards, including Best Paper Awards (2001, 2005) and an Academic Contribution Award (2014) from the Japanese Society of Pharmaceutical Health Care and Sciences. With a strong academic and clinical impact, Dr. Maeda is a leading figure in pharmaceutical advancements, ensuring better patient safety and treatment efficacy. 🏅🔬

Publication Profile

scopus

Educational and Professional Background

Prof. Dr. Yorinobu Maeda has a distinguished background in pharmaceutical sciences, earning his Ph.D. from Hiroshima University in 1990 🎓. His expertise spans infection control, hospital pharmacy specialization, and drug safety leadership, reflecting his dedication to pharmaceutical advancements 💊. With leadership roles in major hospitals 🏥 and an esteemed position as a professor at Fukuyama University 🎓, he has made significant academic and practical contributions to the field. His work continues to shape the future of pharmacy, ensuring patient safety and advancing healthcare practices for better medical outcomes 🌍🔬.

Contributions to Pharmaceutical Sciences

Prof. Dr. Yorinobu Maeda has made significant contributions to pharmaceutical sciences, particularly in drug safety, pharmacokinetics, and dosage optimization 💊🔬. His research focuses on infection control 🦠, renal function-based dosing 🏥, and improving prescription practices, directly enhancing patient safety and treatment efficacy 👨‍⚕️✅. As a Drug Safety Director, he plays a crucial role in advancing pharmaceutical practices, ensuring medications are used effectively and safely. His dedication to optimizing drug therapy and refining medical protocols continues to have a lasting impact on healthcare, improving outcomes for patients worldwide 🌍💉.

Awards and Recognitions

Prof. Dr. Yorinobu Maeda has made remarkable contributions to the field of pharmaceutical healthcare, earning numerous prestigious accolades from the Japanese Society of Pharmaceutical Health Care and Sciences. His achievements include the Best Paper Awards in 2001 and 2005 🏆, as well as the esteemed Academic Contribution Award in 2014 🎓. These honors highlight his dedication to advancing research and implementing pharmacokinetic principles to enhance patient safety and care 🩺. Dr. Maeda’s work stands as a testament to his unwavering commitment to improving healthcare standards and fostering innovation in pharmaceutical sciences. 🌟

Research Focus

Professor Dr. Yorinobu Maeda is an eminent researcher specializing in pharmaceutical sciences, with a primary focus on drug bioavailability, prodrug development, and therapeutic drug monitoring. His work spans areas such as drug absorption, small intestinal bacterial overgrowth diagnosis, and managing adverse drug reactions. Notable research includes the impact of metal ions on drug efficacy and innovative prodrug strategies. Through collaborative studies, he contributes to optimizing drug delivery systems and clinical pharmacotherapy, enhancing patient safety and treatment outcomes. 🧪💊

Publication Top Notes

5-Aminosalicylic Acid Distribution into the Intestinal Membrane Along the Gastrointestinal Tract After Oral Administration in Rats

Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline

Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth

Ester Prodrugs of Levofloxacin to Prevent Chelate Formation in Presence of Aluminium Ion

Study on the method to avoid infusion‑site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells

Effect of aluminium ion on bioavailability of levofloxacin following oral administration of cilexetil ester of levofloxacin as prodrug in rats

 Study on the infusion-site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant

Dosage adjustment of dabigatran etexilate based on creatinine clearance in patients with cardioembolic stroke or atrial fibrillation

Interaction of magnesium oxide with gastric acid secretion inhibitors in clinical pharmacotherapy

 

Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Assist. Prof. Dr. Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Xuzhou Medical University, China

Author Profile

🎓Early Academic Pursuits 

Liqun Jiang began his academic journey with a deep interest in pharmaceutical sciences and biotechnology. His foundational studies were driven by a passion for discovering innovative solutions to pressing medical challenges. During his early years, Jiang demonstrated exceptional aptitude in the fields of drug development and delivery systems, excelling in both theoretical and applied sciences. These formative experiences laid the groundwork for his future endeavors in advanced pharmaceutical research. Jiang’s dedication to academic excellence led him to pursue specialized training and advanced education, equipping him with the knowledge and skills essential for groundbreaking contributions to medical science.

🌟Professional Endeavors 

Currently serving as an Associate Professor at Xuzhou Medical University, Liqun Jiang has established himself as a key figure in pharmaceutical engineering. His role extends beyond teaching, as he actively participates in high-impact research initiatives. A youth member of the Pharmaceutical Engineering Committee of the Chinese Pharmaceutical Society, Jiang is deeply involved in projects focused on novel drug delivery systems, particularly for respiratory diseases.

He has been instrumental in nearly 10 prestigious research projects, including the national 863 Program and major drug innovation programs. Jiang has successfully overseen the development of approximately 10 products, ranging from pharmaceuticals and disinfection solutions to specialized medical foods. His collaborative efforts with pharmaceutical companies have led to the development of a drug liposome inhalation agent, which has now progressed to pilot production stages.

🔬Contributions and Research Focus 

Jiang Liqun’s research is primarily centered on novel drug delivery systems for respiratory diseases, with a particular emphasis on pulmonary edema. His contributions to the field are both diverse and impactful, including: Developing pressure-sensitive multivesicular liposomes for delivering amlodipine besylate, Innovating therapies with exogenous eNOS genes to combat high-altitude pulmonary edema, Utilizing mesenchymal stem cell exosomes for advanced inhalation therapies, Designing high-efficiency powder mist inhalants for high-altitude conditions.

🏆Accolades and Recognition 

Liqun Jiang’s academic and professional achievements have garnered widespread recognition. His research contributions are evidenced by: Nearly 30 peer-reviewed publications in reputed journals, 10 authorized patents, with 8 more under processing, An impressive citation index of 312, reflecting the high impact of his work, Close collaborations with pharmaceutical companies, leading to tangible advancements in drug development and commercialization, Jiang’s dedication to his field is further highlighted by his active participation in the Chinese Pharmaceutical Society, where he contributes as a youth member in shaping the future of pharmaceutical engineering.

🌏Impact and Influence 

Jiang Liqun’s work has had a profound impact on both academia and industry. His innovative strategies for addressing respiratory diseases have paved the way for safer, more effective therapeutic interventions. By integrating cutting-edge drug delivery systems into clinical practice, Jiang has set a benchmark in the treatment of pulmonary conditions. His ability to bridge the gap between research and application has made him a valuable collaborator for pharmaceutical companies seeking to bring advanced therapies to market.

🌟Legacy and Future Contributions 

Jiang Liqun’s legacy lies in his relentless pursuit of innovation and excellence in pharmaceutical research. His groundbreaking work in drug delivery systems has already influenced the development of treatments for high-altitude pulmonary edema and other respiratory conditions. Looking ahead, Jiang aims to expand his research into broader areas of pulmonary medicine, focusing on the use of biotechnology and nanotechnology in drug development. He envisions a future where precision medicine and targeted therapies play a pivotal role in treating respiratory diseases, improving outcomes for patients worldwide. Jiang is committed to mentoring the next generation of researchers and fostering collaborations that advance the frontiers of pharmaceutical science.

🌟Final Thoughts 

With a career marked by innovation, dedication, and impactful contributions, Liqun Jiang exemplifies the qualities of a trailblazing researcher. His work continues to shape the future of respiratory medicine, leaving an indelible mark on both academia and industry. Through his ongoing efforts, Jiang inspires a new wave of scientific inquiry and collaboration, ensuring his legacy will resonate for years to come.

📖Notable Publications

Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema
  • Authors : Li, H., Liu, S., Dai, W., … Jin, F., Jiang, L.
  • Journal: Controlled Release
  • Year: 2024
Inhalation of panaxadiol alleviates lung inflammation via inhibiting TNFA/TNFAR and IL7/IL7R signaling between macrophages and epithelial cells
  • Authors : Wang, Y., Wei, H., Song, Z., … Shu, Q., Xie, Y.
  • Journal: Ginseng Research
  • Year: 2024
Dry Powder Formulations for Inhalation Require a Smaller Aerodynamic Diameter for Usage at High Altitude
A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment
A simple liposome-based bionic bacterium for tumor treatment by re-education of tumor-associated microphages in combination with chemotherapy